These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36627003)

  • 21. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active ingredients and molecular targets of
    Zheng Y; Ji S; Li X; Feng Q
    PeerJ; 2022; 10():e13737. PubMed ID: 35873910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revealing active ingredients, potential targets, and action mechanism of Ermiao fang for treating endometritis based on network pharmacology strategy.
    Zhang C; Su T; Yu D; Wang F; Yue C; Wang HQ
    J Ethnopharmacol; 2020 Oct; 260():113051. PubMed ID: 32505843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology.
    Yu Q; Chen Z; Liu M; Meng Y; Li X; Li B; Du J
    J Ethnopharmacol; 2022 Oct; 297():115531. PubMed ID: 35840058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology.
    Zhang C; Xiang H; Wang J; Shao G; Ding P; Gao Y; Xu H; Ji G; Wu T
    J Ethnopharmacol; 2023 Dec; 317():116676. PubMed ID: 37279814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology.
    Yang M; Yan Q; Luo Y; Wang B; Deng S; Luo H; Ye B; Wang X
    Front Pharmacol; 2023; 14():1016967. PubMed ID: 36744264
    [No Abstract]   [Full Text] [Related]  

  • 27. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
    Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
    Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma.
    Huang J; Guo W; Cheung F; Tan HY; Wang N; Feng Y
    Am J Chin Med; 2020; 48(1):161-182. PubMed ID: 31964157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of Shashen-Maidong herb pair in treating hepatocellular carcinoma using network pharmacology and experimental validation.
    Xie YQ; Yan FN; Yu LH; Yan HW; Kong YX; Yang ZY
    J Ethnopharmacol; 2025 Jan; 337(Pt 3):118954. PubMed ID: 39419302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yu Ping Feng San Exert Anti-Angiogenesis Effects through the Inhibition of TSLP-STAT3 Signaling Pathways in Hepatocellular Carcinoma.
    Yuan Q; Yao F; Zhou L; Liang G; Song X; Jiang G; Zhou M; Zhang L
    Evid Based Complement Alternat Med; 2019; 2019():1947156. PubMed ID: 31885639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A network pharmacology integrated serum pharmacochemistry strategy for uncovering efficacy of YXC on hepatocellular carcinoma.
    Zhou TT; Zhu WJ; Feng H; Ni Y; Li ZW; Sun DD; Li L; Tan JN; Yu CT; Shen WX; Cheng HB
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117125. PubMed ID: 37699493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics.
    Wan Y; Jiang H; Liu Z; Bai C; Lian Y; Zhang C; Zhang Q; Huang J
    Curr Pharm Des; 2024; 30(24):1894-1911. PubMed ID: 38747231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing component formula suppresses lung cancer by blocking DTL-mediated PDCD4 ubiquitination to regulate the MAPK/JNK pathway.
    Fan Q; Lu Q; Wang G; Zhu W; Teng L; Chen W; Bi L
    J Ethnopharmacol; 2022 Dec; 299():115546. PubMed ID: 35850313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated strategy of network pharmacology, molecular docking, HPLC-DAD and mice model for exploring active ingredients and pharmacological mechanisms of Penthorum chinense Pursh against alcoholic liver injury.
    Jiang Y; Zhong M; Zhan H; Tao X; Zhang Y; Mao J; Geng Z; Gao B
    J Ethnopharmacol; 2022 Nov; 298():115589. PubMed ID: 35926779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanism and experimental verification of Ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology: Ixeris sonchifolia Induces Hepatocellular Carcinoma Apoptosis via the PI3K/AKT Pathway.
    Liu BJ; Guan YY; Qiao LX; Zhang JM; Li AJ; Yang PX; Gao YX; Chen DX; Wang CX; Wu J
    J Ethnopharmacol; 2024 Jun; 327():117994. PubMed ID: 38437889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the
    Jiang N; Li H; Sun Y; Zeng J; Yang F; Kantawong F; Wu J
    Front Pharmacol; 2021; 12():618522. PubMed ID: 33746755
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhancing NKT cell-mediated immunity against hepatocellular carcinoma: Role of XYXD in promoting primary bile acid synthesis and improving gut microbiota.
    Deng Z; Ouyang Z; Mei S; Zhang X; Li Q; Meng F; Hu Y; Dai X; Zhou S; Mao K; Huang C; Dai J; Yi C; Tan N; Feng T; Long H; Tian X
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116945. PubMed ID: 37490989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mechanism of Bupleurum scorzonerifolium and Paeonia lactiflora herbal pair against liver cancer: an exploration based on UPLC-Q-TOF-MS combined with network pharmacology].
    Zou X; Sui Y; Tang XY; Zhang R; Shu Q; Gong T; Wu S; Sun ZW; Li WL; Qu ZY
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3597-3608. PubMed ID: 35850814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology.
    Yin X; Li J; Hao Z; Ding R; Qiao Y
    Front Cell Infect Microbiol; 2022; 12():964469. PubMed ID: 36046748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.